Literature DB >> 21172518

Existing general population models inaccurately predict lung cancer risk in patients referred for surgical evaluation.

James M Isbell1, Stephen Deppen, Joe B Putnam, Jonathan C Nesbitt, Eric S Lambright, Aaron Dawes, Pierre P Massion, Theodore Speroff, David R Jones, Eric L Grogan.   

Abstract

BACKGROUND: Patients undergoing resections for suspicious pulmonary lesions have a 9% to 55% benign rate. Validated prediction models exist to estimate the probability of malignancy in a general population and current practice guidelines recommend their use. We evaluated these models in a surgical population to determine the accuracy of existing models to predict benign or malignant disease.
METHODS: We conducted a retrospective review of our thoracic surgery quality improvement database (2005 to 2008) to identify patients who underwent resection of a pulmonary lesion. Patients were stratified into subgroups based on age, smoking status, and fluorodeoxyglucose positron emission tomography (PET) results. The probability of malignancy was calculated for each patient using the Mayo and solitary pulmonary nodules prediction models. Receiver operating characteristic and calibration curves were used to measure model performance.
RESULTS: A total of 189 patients met selection criteria; 73% were malignant. Patients with preoperative PET scans were divided into four subgroups based on age, smoking history, and nodule PET avidity. Older smokers with PET-avid lesions had a 90% malignancy rate. Patients with PET-nonavid lesions, PET-avid lesions with age less than 50 years, or never smokers of any age had a 62% malignancy rate. The area under the receiver operating characteristic curve for the Mayo and solitary pulmonary nodules models was 0.79 and 0.80, respectively; however, the models were poorly calibrated (p<0.001).
CONCLUSIONS: Despite improvements in diagnostic and imaging techniques, current general population models do not accurately predict lung cancer among patients referred for surgical evaluation. Prediction models with greater accuracy are needed to identify patients with benign disease to reduce nontherapeutic resections.
Copyright © 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21172518      PMCID: PMC3748597          DOI: 10.1016/j.athoracsur.2010.08.054

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  18 in total

1.  Prevalence of benign disease in patients undergoing resection for suspected lung cancer.

Authors:  Michael A Smith; Richard J Battafarano; Bryan F Meyers; Jennifer Bell Zoole; Joel D Cooper; G Alexander Patterson
Journal:  Ann Thorac Surg       Date:  2006-05       Impact factor: 4.330

2.  Solitary pulmonary nodules: pathological outcome of 150 consecutively resected lesions.

Authors:  Ben Davies; Sudip Ghosh; David Hopkinson; Roger Vaughan; Gaetano Rocco
Journal:  Interact Cardiovasc Thorac Surg       Date:  2004-12-17

Review 3.  Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition).

Authors:  Momen M Wahidi; Joseph A Govert; Ranjit K Goudar; Michael K Gould; Douglas C McCrory
Journal:  Chest       Date:  2007-09       Impact factor: 9.410

4.  Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part I. Theory.

Authors:  J W Gurney
Journal:  Radiology       Date:  1993-02       Impact factor: 11.105

5.  Clinical experience with radiotracer-guided thoracoscopic biopsy of small, indeterminate lung nodules.

Authors:  Brendon M Stiles; Talissa A Altes; David R Jones; K Robert Shen; Gorav Ailawadi; Spencer B Gay; Juan Olazagasti; Patrice K Rehm; Thomas M Daniel
Journal:  Ann Thorac Surg       Date:  2006-10       Impact factor: 4.330

6.  The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules.

Authors:  S J Swensen; M D Silverstein; D M Ilstrup; C D Schleck; E S Edell
Journal:  Arch Intern Med       Date:  1997-04-28

7.  Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer.

Authors:  Carolyn E Reed; David H Harpole; Katherine E Posther; Sandra L Woolson; Robert J Downey; Bryan F Meyers; Robert T Heelan; Homer A MacApinlac; Sin-Ho Jung; Gerard A Silvestri; Barry A Siegel; Valerie W Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2003-12       Impact factor: 5.209

8.  Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).

Authors:  Peter B Bach; Gerard A Silvestri; Morgan Hanger; James R Jett
Journal:  Chest       Date:  2007-09       Impact factor: 9.410

9.  An expanded risk prediction model for lung cancer.

Authors:  Margaret R Spitz; Carol J Etzel; Qiong Dong; Christopher I Amos; Qingyi Wei; Xifeng Wu; Waun Ki Hong
Journal:  Cancer Prev Res (Phila)       Date:  2008-09

10.  Radiotracer-guided thoracoscopic resection is a cost-effective technique for the evaluation of subcentimeter pulmonary nodules.

Authors:  Eric L Grogan; George J Stukenborg; Alykhan S Nagji; Winsor Simmons; Benjamin D Kozower; David R Jones; Thomas M Daniel
Journal:  Ann Thorac Surg       Date:  2008-09       Impact factor: 4.330

View more
  26 in total

1.  Solid pulmonary nodule risk assessment and decision analysis: comparison of four prediction models in 285 cases.

Authors:  Simone Perandini; Gian Alberto Soardi; Massimiliano Motton; Arianna Rossi; Manuel Signorini; Stefania Montemezzi
Journal:  Eur Radiol       Date:  2015-12-08       Impact factor: 5.315

Review 2.  Epigenetics of lung cancer.

Authors:  Scott M Langevin; Robert A Kratzke; Karl T Kelsey
Journal:  Transl Res       Date:  2014-03-12       Impact factor: 7.012

3.  Multicenter external validation of two malignancy risk prediction models in patients undergoing 18F-FDG-PET for solitary pulmonary nodule evaluation.

Authors:  Simone Perandini; G A Soardi; A R Larici; A Del Ciello; G Rizzardi; A Solazzo; L Mancino; F Zeraj; M Bernhart; M Signorini; M Motton; S Montemezzi
Journal:  Eur Radiol       Date:  2016-09-15       Impact factor: 5.315

4.  Segmental 18F-FDG-PET/CT in a single pulmonary nodule: a better cost/effectiveness strategy.

Authors:  Marco Spadafora; Leonardo Pace; Luigi Mansi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-01       Impact factor: 9.236

5.  Comparison of three mathematical prediction models in patients with a solitary pulmonary nodule.

Authors:  Xuan Zhang; Hong-Hong Yan; Jun-Tao Lin; Ze-Hua Wu; Jia Liu; Xu-Wei Cao; Xue-Ning Yang
Journal:  Chin J Cancer Res       Date:  2014-12       Impact factor: 5.087

6.  Indeterminate pulmonary nodules: risk for having or for developing lung cancer?

Authors:  Pierre P Massion; Ronald C Walker
Journal:  Cancer Prev Res (Phila)       Date:  2014-10-27

Review 7.  Developing prediction models for clinical use using logistic regression: an overview.

Authors:  Maren E Shipe; Stephen A Deppen; Farhood Farjah; Eric L Grogan
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

Review 8.  The state of molecular biomarkers for the early detection of lung cancer.

Authors:  Mohamed Hassanein; J Clay Callison; Carol Callaway-Lane; Melinda C Aldrich; Eric L Grogan; Pierre P Massion
Journal:  Cancer Prev Res (Phila)       Date:  2012-06-11

9.  Predicting lung cancer prior to surgical resection in patients with lung nodules.

Authors:  Stephen A Deppen; Jeffrey D Blume; Melinda C Aldrich; Sarah A Fletcher; Pierre P Massion; Ronald C Walker; Heidi C Chen; Theodore Speroff; Catherine A Degesys; Rhonda Pinkerman; Eric S Lambright; Jonathan C Nesbitt; Joe B Putnam; Eric L Grogan
Journal:  J Thorac Oncol       Date:  2014-10       Impact factor: 15.609

10.  Cost-effectiveness of initial diagnostic strategies for pulmonary nodules presenting to thoracic surgeons.

Authors:  Stephen A Deppen; William T Davis; Elizabeth A Green; Otis Rickman; Melinda C Aldrich; Sarah Fletcher; Joseph B Putnam; Eric L Grogan
Journal:  Ann Thorac Surg       Date:  2014-07-31       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.